Dr. Katy Tsai, MD
Claim this profileUCSF Helen Diller Family Comprehensive Cancer Center
Studies Skin Cancer
Studies Melanoma
11 reported clinical trials
15 drugs studied
Area of expertise
1Skin Cancer
Stage IV
Stage III
BRAF positive
2Melanoma
Stage IV
Stage III
KIT positive
Affiliated Hospitals
Clinical Trials Katy Tsai, MD is currently running
RP1 + Nivolumab
for Cancer
This trial tests a modified virus (RP1) and an immune-boosting drug (nivolumab) in adults with advanced or treatment-resistant solid tumors. RP1 kills cancer cells and helps the immune system recognize them, while nivolumab enhances the immune response. Nivolumab has been approved for treating advanced melanoma, renal cell carcinoma, non-small cell lung cancer, and other malignancies.
Recruiting1 award Phase 29 criteria
RP1
for Advanced Skin Cancer in Transplant Patients
This trial tests RP1, a modified virus, in organ transplant recipients with advanced skin cancer. RP1 works by killing cancer cells and boosting the immune system to fight the cancer. The HIV-1 accessory protein Vpr has been shown to induce cell cycle arrest and kill tumor cells by apoptosis.
Recruiting1 award Phase 1 & 210 criteria
More about Katy Tsai, MD
Clinical Trial Related2 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Katy Tsai, MD has experience with
- Nivolumab
- RP1
- Binimetinib
- Imatinib
- ABM-1310
- Cobimetinib
Breakdown of trials Katy Tsai, MD has run
Skin Cancer
Melanoma
Uterine Tumors
Solid Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Katy Tsai, MD specialize in?
Katy Tsai, MD focuses on Skin Cancer and Melanoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage III.
Is Katy Tsai, MD currently recruiting for clinical trials?
Yes, Katy Tsai, MD is currently recruiting for 7 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Katy Tsai, MD has studied deeply?
Yes, Katy Tsai, MD has studied treatments such as Nivolumab, RP1, Binimetinib.
What is the best way to schedule an appointment with Katy Tsai, MD?
Apply for one of the trials that Katy Tsai, MD is conducting.
What is the office address of Katy Tsai, MD?
The office of Katy Tsai, MD is located at: UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California 94143 United States. This is the address for their practice at the UCSF Helen Diller Family Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.